Capmatinib­associated interstitial lung disease in a patient with lung adenocarcinoma harboring a skipping mutation of mesenchymal­epithelial transition exon 14: A case report.

Lee, Bing-Jie; Chang, Cheng-Yu

Capmatinibassociated interstitial lung disease in a patient with lung adenocarcinoma harboring a skipping mutation of mesenchymalepithelial transition exon 14: A case report.

Lee, Bing-Jie; Chang, Cheng-Yu.

Afiliación

Lee BJ; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City 22000, Taiwan, R.O.C.
Chang CY; Division of Chest Medicine, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City 22000, Taiwan, R.O.C.

Oncol Lett ; 26(4): 455, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37720677

Palabras clave

capmatinib; interstitial lung disease; mesenchymal-epithelial transition exon 14 skipping; mesenchymal-epithelial transition inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2023 Tipo del documento: Article